Vectors Research Management’s MetLife MET Stock Holding History

Vectors Research Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-153	Closed	-$10K	–	342
2022 Q2	$10K	Buy	153 +1	+0.7%	+$66	﹤0.01%	364
2022 Q1	$11K	Hold	152	–	–	﹤0.01%	345
2021 Q4	$9K	Buy	152 +1	+0.7%	+$63	﹤0.01%	437
2021 Q3	$9K	Hold	151	–	–	﹤0.01%	375
2021 Q2	$9K	Buy	151 +56	+59%	+$3.55K	﹤0.01%	396
2021 Q1	$6K	Sell	95 -200	-68%	-$11K	﹤0.01%	377
2020 Q4	$14K	Buy	295 +200	+211%	+$8.67K	﹤0.01%	307
2020 Q3	$4K	Hold	95	–	–	﹤0.01%	355
2020 Q2	$3K	Hold	95	–	–	﹤0.01%	375
2020 Q1	$3K	Hold	95	–	–	﹤0.01%	397
2019 Q4	$5K	Hold	95	–	–	﹤0.01%	421
2019 Q3	$4K	Hold	95	–	–	﹤0.01%	377
2019 Q2	$5K	Hold	95	–	–	﹤0.01%	319
2019 Q1	$4K	Hold	95	–	–	﹤0.01%	347
2018 Q4	$4K	Hold	95	–	–	﹤0.01%	541
2018 Q3	$4K	Buy	+95	New	+$4.34K	﹤0.01%	396

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vectors Research Management's MET Position: Q3 2022 in Review

Vectors Research Management sold out of MetLife (MET) in Q3 2022, closing a stake of 153 shares — an estimated $10K sold.

Vectors Research Management first reported a position in MET in Q3 2018 and held it in 16 quarters. The position peaked at $14K in Q4 2020. 1,193 funds tracked by Wall St. Rank hold MET as of Q3 2022.

Vectors Research Management reported no remaining MetLife position as of Q3 2022 after selling out during the quarter.
Vectors Research Management sold 153 MetLife shares in Q3 2022, an estimated $10K.
Vectors Research Management first reported a position in MetLife in Q3 2018 and held it in 16 quarters.
Vectors Research Management's MetLife position peaked at $14K in Q4 2020.
1,193 funds tracked by Wall St. Rank held MetLife as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.